Menu
Stakeholders have from today through March 14 to comment on the Biden administration's proposal to delay a controversial Trump administration about the cost of insulin at 340B health centers until July 20. | Shutterstock

Biden Wants to Delay 340B Health Center Insulin Rule Again, to July 20

In Federal, Regulatory Tom Mirga
The Biden administration proposes once again to push back, this time from March 22 to July 20, the effective date of the Trump administration’s controversial final rule to require health centers to provide insulin and injectable epinephrine to low-income patients at the price centers pay for those drugs under the 340B program.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.